THE PENNANT GROUP, INC. Operating Income
THE PENNANT GROUP, INC. (PNTG) reported Operating Income of $17.19 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- THE PENNANT GROUP, INC. operating income (loss) for the quarter ending 2026-06-30 was $17.19M, a 49.08% increase year-over-year.
- THE PENNANT GROUP, INC. operating income (loss) for the quarter ending 2026-03-31 was $17.30M, a 36.77% increase year-over-year.
- THE PENNANT GROUP, INC. operating income (loss) for the quarter ending 2025-12-31 was $17.47M, a 89.15% increase year-over-year.
- THE PENNANT GROUP, INC. operating income (loss) for the quarter ending 2025-09-30 was $10.24M, a 5.15% decline year-over-year.
- THE PENNANT GROUP, INC. operating income (loss) for fiscal 2025 was $51.89M, a 36.13% increase from fiscal 2024.
- THE PENNANT GROUP, INC. operating income (loss) for fiscal 2024 was $38.12M, a 51.44% increase from fiscal 2023.
- THE PENNANT GROUP, INC. operating income (loss) for fiscal 2023 was $25.17M, a 97.57% increase from fiscal 2022.
- THE PENNANT GROUP, INC. operating income (loss) for fiscal 2022 was $12.74M, a 171.33% increase from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.19M 10-Q · filed 2026-08-05 | $34.49M 10-Q · filed 2026-08-05 | $51.96M derived: sum of 3 quarters · filed 2026-08-05 | $62.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $17.30M 10-Q · filed 2026-05-06 | $34.77M derived: sum of 2 quarters · filed 2026-05-06 | $45.01M derived: sum of 3 quarters · filed 2026-05-06 | $56.54M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $17.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $27.71M derived: sum of 2 quarters · filed 2026-02-26 | $39.24M derived: sum of 3 quarters · filed 2026-08-05 | $51.89M 10-K · filed 2026-02-26 |
| 2025-09-30 | $10.24M 10-Q · filed 2025-11-05 | $21.77M derived: sum of 2 quarters · filed 2026-08-05 | $34.42M 10-Q · filed 2025-11-05 | $43.65M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $11.53M 10-Q · filed 2026-08-05 | $24.18M 10-Q · filed 2026-08-05 | $33.41M derived: sum of 3 quarters · filed 2026-08-05 | $44.21M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $12.65M 10-Q · filed 2026-05-06 | $21.89M derived: sum of 2 quarters · filed 2026-05-06 | $32.68M derived: sum of 3 quarters · filed 2026-05-06 | $42.24M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $9.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $20.03M derived: sum of 2 quarters · filed 2026-02-26 | $29.59M derived: sum of 3 quarters · filed 2026-02-26 | $38.12M 10-K · filed 2026-02-26 |
| 2024-09-30 | $10.79M 10-Q · filed 2025-11-05 | $20.36M derived: sum of 2 quarters · filed 2025-11-05 | $28.88M 10-Q · filed 2025-11-05 | $36.45M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $9.56M 10-Q · filed 2025-08-06 | $18.09M 10-Q · filed 2025-08-06 | $25.65M derived: sum of 3 quarters · filed 2026-02-26 | $32.71M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $8.52M 10-Q · filed 2025-05-06 | $16.09M derived: sum of 2 quarters · filed 2026-02-26 | $23.15M derived: sum of 3 quarters · filed 2026-02-26 | $29.41M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $7.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.63M derived: sum of 2 quarters · filed 2026-02-26 | $20.89M derived: sum of 3 quarters · filed 2026-02-26 | $25.17M 10-K · filed 2026-02-26 |
| 2023-09-30 | $7.06M 10-Q · filed 2024-11-06 | $13.32M derived: sum of 2 quarters · filed 2024-11-06 | $17.60M 10-Q · filed 2024-11-06 | $23.99M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $6.26M 10-Q · filed 2024-08-06 | $10.54M 10-Q · filed 2024-08-06 | $16.93M derived: sum of 3 quarters · filed 2025-02-27 | $24.07M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $4.28M 10-Q · filed 2024-05-06 | $10.66M derived: sum of 2 quarters · filed 2025-02-27 | $17.81M derived: sum of 3 quarters · filed 2025-02-27 | $14.69M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $6.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $13.53M derived: sum of 2 quarters · filed 2025-02-27 | $10.41M derived: sum of 3 quarters · filed 2025-02-27 | $12.74M 10-K · filed 2025-02-27 |
| 2022-09-30 | $7.14M 10-Q · filed 2023-11-07 | $4.03M derived: sum of 2 quarters · filed 2023-11-07 | $6.36M 10-Q · filed 2023-11-07 | $4.17M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$3.12M 10-Q · filed 2023-08-08 | -$789.00K 10-Q · filed 2023-08-08 | -$2.98M derived: sum of 3 quarters · filed 2024-02-28 | -$1.28M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $2.33M 10-Q · filed 2023-05-04 | $137.00K derived: sum of 2 quarters · filed 2024-02-28 | $1.84M derived: sum of 3 quarters · filed 2024-02-28 | $5.41M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$487.00K derived: sum of 2 quarters · filed 2024-02-28 | $3.08M derived: sum of 3 quarters · filed 2024-02-28 | $4.70M 10-K · filed 2024-02-28 |
| 2021-09-30 | $1.70M 10-Q · filed 2022-11-07 | $5.27M derived: sum of 2 quarters · filed 2022-11-07 | $6.88M 10-Q · filed 2022-11-07 | $10.98M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $3.57M 10-Q · filed 2022-08-08 | $5.18M 10-Q · filed 2022-08-08 | $9.27M derived: sum of 3 quarters · filed 2023-02-23 | $13.75M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $1.61M 10-Q · filed 2022-05-09 | $5.71M derived: sum of 2 quarters · filed 2023-02-23 | $10.18M derived: sum of 3 quarters · filed 2023-02-23 | $16.26M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $4.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $8.57M derived: sum of 2 quarters · filed 2023-02-23 | $14.64M derived: sum of 3 quarters · filed 2023-02-23 | $18.92M 10-K · filed 2023-02-23 |
| 2020-09-30 | $4.48M 10-Q · filed 2021-11-08 | $10.55M derived: sum of 2 quarters · filed 2021-11-08 | $14.82M 10-Q · filed 2021-11-08 | $13.43M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $6.08M 10-Q · filed 2021-08-09 | $10.35M 10-Q · filed 2021-08-09 | $8.95M derived: sum of 3 quarters · filed 2022-02-28 | $10.88M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $4.27M 10-Q · filed 2021-05-06 | $2.88M derived: sum of 2 quarters · filed 2022-02-28 | $4.80M derived: sum of 3 quarters · filed 2022-02-28 | $8.12M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $531.00K derived: sum of 2 quarters · filed 2022-02-28 | $3.84M derived: sum of 3 quarters · filed 2022-02-28 | $5.67M 10-K · filed 2022-02-28 |
| 2019-09-30 | $1.93M 10-Q · filed 2020-11-10 | $5.24M derived: sum of 2 quarters · filed 2020-11-10 | $7.07M 10-Q · filed 2020-11-10 | $11.78M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $3.31M 10-Q · filed 2020-08-11 | $5.14M 10-Q · filed 2020-08-11 | $9.86M derived: sum of 3 quarters · filed 2021-02-24 | $15.66M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $1.83M 10-Q · filed 2020-05-13 | $6.54M derived: sum of 2 quarters · filed 2021-02-24 | $12.35M derived: sum of 3 quarters · filed 2021-02-24 | |
| 2018-12-31 | $4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $10.52M derived: sum of 2 quarters · filed 2021-02-24 | $20.63M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $5.80M 10-Q · filed 2019-11-12 | $15.91M 10-Q · filed 2019-11-12 | ||
| 2017-12-31 | $15.40M 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |